NASDAQ:ATNF 180 Life Sciences (ATNF) Stock Price, News & Analysis $3.42 -0.32 (-8.56%) (As of 12:35 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends About 180 Life Sciences Stock (NASDAQ:ATNF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get 180 Life Sciences alerts:Sign Up Key Stats Today's Range$3.38▼$3.7150-Day Range$1.18▼$6.4752-Week Range$1.16▼$17.75Volume207,491 shsAverage Volume825,445 shsMarket Capitalization$3.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.Read More… Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Receive ATNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address ATNF Stock News Headlines180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform IntegrationOctober 31, 2024 | finance.yahoo.com180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of DirectorsOctober 30, 2024 | finance.yahoo.comThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. November 4, 2024 | Porter & Company (Ad)Elray Resources Announces Strategic Sale of Crypto iGaming TechnologyOctober 25, 2024 | markets.businessinsider.comSoaring $1-handle stocks leaping into IBKR’s most-active list may point to market frothOctober 23, 2024 | msn.com180 Life Sciences' Brave Decision To Switch to the iGaming IndustryOctober 18, 2024 | finance.yahoo.com180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial OfficerSeptember 12, 2024 | globenewswire.com180 Life Sciences Corp Ordinary SharesSeptember 3, 2024 | morningstar.comSee More Headlines ATNF Stock Analysis - Frequently Asked Questions How have ATNF shares performed this year? 180 Life Sciences' stock was trading at $4.0565 on January 1st, 2024. Since then, ATNF stock has decreased by 12.2% and is now trading at $3.56. View the best growth stocks for 2024 here. How were 180 Life Sciences' earnings last quarter? 180 Life Sciences Corp. (NASDAQ:ATNF) announced its quarterly earnings results on Monday, August, 12th. The company reported $0.01 earnings per share for the quarter. When did 180 Life Sciences' stock split? 180 Life Sciences shares reverse split before market open on Wednesday, February 28th 2024. The 1-19 reverse split was announced on Wednesday, February 28th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of 180 Life Sciences? Shares of ATNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of 180 Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that 180 Life Sciences investors own include Meta Platforms (META), NIO (NIO), Enterprise Products Partners (EPD), HubSpot (HUBS), Netflix (NFLX), Palantir Technologies (PLTR) and Plug Power (PLUG). Company Calendar Last Earnings8/12/2024Today11/04/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ATNF CUSIPN/A CIK1690080 Webwww.kblmerger.com Phone(650) 507-0669FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,930,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-523.62% Return on Assets-79.41% Debt Debt-to-Equity RatioN/A Current Ratio0.58 Quick Ratio0.58 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.24) per share Price / Book-14.83Miscellaneous Outstanding Shares1,030,000Free Float985,000Market Cap$3.67 million OptionableNo Data Beta0.22 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (NASDAQ:ATNF) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share 180 Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.